Caredx Inc

Caredx Inc

CDNA

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.18B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Caredx IncCaredx Inc-142.5--3%2.80.1
$27.00

Target Price by Analysts

21% upsideCaredx Target Price DetailsTarget Price
$-1.68

Current Fair Value

107.5% downside

Overvalued by 107.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.18 Billion
Enterprise Value$1.12 Billion
Dividend Yield$- (-)
Earnings per Share$-0.4
Beta2.49
Outstanding Shares51,151,794

Return

Return on Equity-2.61%ROE
Return on Assets-1.99%
Return on Invested Capital-3.28%

Valuation & Multiples

P/E Ratio-142.47P/E Ratio
PEG112.07PEG
Price to Sales2.79Price to Sales
Price to Book Ratio3.72Price to Book Ratio
Enterprise Value to Revenue2.71
Enterprise Value to EBIT-102.68
Enterprise Value to Net Income-137
Total Debt to Enterprise0.02
Debt to Equity0.06Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
April 30, 2026
EPS Estimate
$-0.03
Average shareholder expectation
Revenue Estimate
$100.40 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 5, 2026
EPS Estimate
$0.22
Average shareholder expectation
Revenue Estimate
$113.82 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls20,300 73.91%
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %102.75% 3.41%
Total Invested$911.99M 7.20%
Investors Holding190 11.00%

ESG Score

No data

About Caredx Inc

CEO: Peter Maag

Relevant Senate Committees

Finance

This committee controls taxation, trade, and entitlement spending, crucially including Medicare and Medicaid. Its decisions on reimbursement rates for medical services, including laboratory tests, are a primary financial driver for companies like Caredx.

Appropriations

This committee allocates discretionary federal spending. Its subcommittees determine precise funding for health agencies (NIH, CDC, VA) and research programs, directly impacting the potential for federal contracts and grants that Caredx could receive or benefit from.

Health, Education, Labor, and Pensions

This committee directly regulates key agencies like the FDA (which oversees diagnostic tests) and NIH (a major source of medical research funding). Its legislative decisions on health policy, approvals, and research funding directly impact Caredx's industry and operations.

Veterans' Affairs

This committee oversees the Department of Veterans Affairs (VA). The VA is a major healthcare provider, and its funding and service decisions directly impact government healthcare contractors, including potential providers of medical lab services like Caredx.